BioCentury
ARTICLE | Finance

Catalyst-driven week in venture and public equity: Finance Report

Follow-ons by Cogen, Centessa and Iambic’s venture round follow clinical data

November 15, 2025 1:23 AM UTC

Several of the week’s top venture and public equity financings were driven by clinical catalysts.

San Diego-based Iambic Therapeutics Inc. announced the biggest venture round of the week, raising about $100 million in a financing of undisclosed series. The company’s AI-guided molecule design platform has produced a lead HER2-targeting candidate, IAM1363, that recently showed activity in the clinic...